Instil Bio (TIL) Free Cash Flow (2020 - 2026)

Instil Bio has reported Free Cash Flow for 7 years, with the latest figure at -$4.6 million in Q2 2026.

• On a quarterly basis, Free Cash Flow rose 68.8% year-over-year to -$4.6 million in Q2 2026; TTM through Jun 2026 was -$23.3 million, a 55.99% increase from a year earlier, with the FY2025 full-year figure at -$36.2 million, up 39.74% from the prior year.
• Free Cash Flow was -$4.6 million for Q2 2026 at Instil Bio, down from -$1.3 million in the prior quarter.
• The five-year high for Free Cash Flow was -$1.3 million in Q1 2026, with the low at -$75.3 million in Q1 2022.
• Average Free Cash Flow over 5 years is -$26.1 million, with a median of -$14.6 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Free Cash Flow plunged 180.31% in 2022, then jumped 73.12% in 2023.
• Over 5 years, Free Cash Flow stood at -$50.0 million in 2022, then surged by 73.12% to -$13.4 million in 2023, then increased by 12.14% to -$11.8 million in 2024, then soared by 40.75% to -$7.0 million in 2025, then soared by 34.79% to -$4.6 million in 2026.
• The last three Free Cash Flow figures came in at -$4.6 million (Q2 2026), -$1.3 million (Q1 2026), and -$7.0 million (Q4 2025), per Business Quant data.